SCHEMBL742718

SCHEMBL742718

CCCCCNC(O)=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9533605 0.97 EPHX1 (0.56)
SCHEMBL9532822 0.97 EPHX1 (0.56)
SCHEMBL9169691 0.97 EPHX1 (0.50)
SCHEMBL10341251 0.97 EPHX1 (0.56)
SCHEMBL3617139 0.97 EPHX1 (0.56)
SCHEMBL11098408 0.97 EPHX1 (0.56)
SCHEMBL9175843 0.97 EPHX1 (0.50)
SCHEMBL28066445 0.95 EPHX1 (0.54)
SCHEMBL1730483 0.93 EPHX1 (0.46)
SCHEMBL689159 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114502179-A Method for preparing aqueous formulations containing manganese complexes, formulations and methods of treatment 加莱拉实验室有限责任公司 2022-05-13 CN claimed
CN-111902147-A Combination cancer therapy of pentaazamacrocycle complexes and platinum-based anticancer agents 加莱拉实验室有限责任公司 2020-11-06 CN claimed
WO-2010012793-A1 FUNGICIDE AMINOTHIAZOLE DERIVATIVES BAYER CROPSCIENCE SA (FR) 2010-02-04 WO claimed
US-7196108-B2 Bicyclic heterocycles for the treatment of diabetes and other diseases INCYTE SAN DIEGO INC. (US) 2007-03-27 US claimed
US-20060160796-A1 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases PFAHL MAGNUS 2006-07-20 US claimed
EP-1487446-A4 BICYCLIC HETEROCYCLES FOR THE TREATMENT OF DIABETES AND OTHER DISEASES INCYTE SAN DIEGO INC (US) 2006-04-19 EP claimed
EP-1487446-A2 BICYCLIC HETEROCYCLES FOR THE TREATMENT OF DIABETES AND OTHER DISEASES Incyte San Diego, Inc. (US) 2004-12-22 EP claimed
US-20040034004-A1 Bicyclic heterocycles for the treatment of diabetes and other diseases ORTHO MCNEIL PHARMACEUTICAL INC. 2004-02-19 US claimed
WO-2003075858-A2 BICYCLIC HETEROCYCLES FOR THE TREATMENT OF DIABETES AND OTHER DISEASES INCYTE SAN DIEGO INCORPORATED (US) 2003-09-18 WO claimed
EP-1042282-A1 METHOD FOR PREPARING AROMATIC THIOLS AND DERIVATIVES, REAGENTS, INTERMEDIATE PRODUCTS AND METHOD FOR OBTAINING THEM RHODIA CHIMIE (FR) 2000-10-11 EP claimed
CN-1191530-A Manganese or iron complexes of nitrogen-contg. macrocyclic ligands effective as catalysts for dismutating superoxide MONSANTO CO (US) 1998-08-26 CN claimed
EP-0598753-B1 MANGANESE COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS EFFECTIVE AS CATALYSTS FOR DISMUTATING SUPEROXIDE MONSANTO CO (US) 1998-03-18 EP claimed
EP-0586585-A4 1994-08-31 EP claimed
EP-0586585-A1 1,2-DIHYDROPYRIDO(3,4-B)PYRAZINES AS FUNGICIDES SOUTHERN RESEARCH INSTITUTE (US) 1994-03-16 EP claimed
EP-0405233-B1 Diphenylurea derivatives MITSUBISHI CHEM IND (JP) 1993-10-27 EP claimed
WO-1992020680-A1 1,2-DIHYDROPYRIDO(3,4-B)PYRAZINES AS FUNGICIDES SOUTHERN RESEARCH INSTITUTE (US) 1992-11-26 WO claimed
US-5095017-A 1,2-dihydropyrido(3,4,-b)pyrazines as fungicides SOUTHERN RESEARCH INSTITUTE (US) 1992-03-10 US claimed
EP-0405233-A1 Diphenylurea derivatives MITSUBISHI KASEI CORPORATION (JP) 1991-01-02 EP claimed
EP-0000640-B1 TETRAHYDRO-S-TRIAZINE THIONES, PROCESS FOR THEIR PREPARATION AND ACARICIDAL COMPOSITIONS CONTAINING THEM. Pfizer Limited (GB) 1981-06-03 EP claimed
EP-0000640-A1 Tetrahydro-s-triazine thiones, process for their preparation and acaricidal compositions containing them. Pfizer Limited (GB) 1979-02-07 EP claimed